HEADER VIRAL PROTEIN 12-JUN-08 2VVY TITLE STRUCTURE OF VACCINIA VIRUS PROTEIN B14 COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROTEIN B15; COMPND 3 CHAIN: A, B, C, D; COMPND 4 SYNONYM: B14; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: VACCINIA VIRUS; SOURCE 3 ORGANISM_TAXID: 10245; SOURCE 4 STRAIN: WESTERN RESERVE; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: B834(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET-28A KEYWDS IKK, IKK BETA, BCL-2 FAMILY, EARLY PROTEIN, HOST-VIRUS INTERACTION, KEYWDS 2 VIRAL PROTEIN, VACCINIA VIRUS, IMMUNOMODULATOR, NF-KB ACTIVATION EXPDTA X-RAY DIFFRACTION AUTHOR S.C.GRAHAM,M.W.BAHAR,S.COORAY,R.A.-J.CHEN,D.M.WHALEN,N.G.A.ABRESCIA, AUTHOR 2 D.ALDERTON,R.J.OWENS,D.I.STUART,G.L.SMITH,J.M.GRIMES REVDAT 4 16-OCT-24 2VVY 1 REMARK REVDAT 3 08-MAY-19 2VVY 1 REMARK LINK REVDAT 2 24-FEB-09 2VVY 1 VERSN REVDAT 1 26-AUG-08 2VVY 0 JRNL AUTH S.C.GRAHAM,M.W.BAHAR,S.COORAY,R.A.-J.CHEN,D.M.WHALEN, JRNL AUTH 2 N.G.A.ABRESCIA,D.ALDERTON,R.J.OWENS,D.I.STUART,G.L.SMITH, JRNL AUTH 3 J.M.GRIMES JRNL TITL VACCINIA VIRUS PROTEINS A52 AND B14 SHARE A BCL-2-LIKE FOLD JRNL TITL 2 BUT HAVE EVOLVED TO INHIBIT NF-KAPPAB RATHER THAN APOPTOSIS JRNL REF PLOS PATHOG. V. 4 E128 2008 JRNL REFN ISSN 1553-7366 JRNL PMID 18704168 JRNL DOI 10.1371/JOURNAL.PPAT.1000128 REMARK 2 REMARK 2 RESOLUTION. 2.69 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.69 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 46.27 REMARK 3 MIN(FOBS/SIGMA_FOBS) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 99.2 REMARK 3 NUMBER OF REFLECTIONS : 36439 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.224 REMARK 3 R VALUE (WORKING SET) : 0.223 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.900 REMARK 3 FREE R VALUE TEST SET COUNT : 1783 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 46.2793 - 6.3280 0.98 2600 151 0.1716 0.1646 REMARK 3 2 6.3280 - 5.0247 0.99 2711 107 0.1805 0.1981 REMARK 3 3 5.0247 - 4.3901 1.00 2679 111 0.1596 0.1950 REMARK 3 4 4.3901 - 3.9889 1.00 2716 121 0.1666 0.1772 REMARK 3 5 3.9889 - 3.7032 1.00 2659 162 0.1934 0.2353 REMARK 3 6 3.7032 - 3.4849 1.00 2691 144 0.2272 0.2987 REMARK 3 7 3.4849 - 3.3104 1.00 2653 161 0.2452 0.2808 REMARK 3 8 3.3104 - 3.1664 1.00 2709 139 0.2592 0.2752 REMARK 3 9 3.1664 - 3.0445 1.00 2689 126 0.2722 0.2416 REMARK 3 10 3.0445 - 2.9395 1.00 2600 170 0.3026 0.2853 REMARK 3 11 2.9395 - 2.8476 1.00 2713 167 0.3375 0.3537 REMARK 3 12 2.8476 - 2.7662 1.00 2659 125 0.3612 0.4130 REMARK 3 13 2.7662 - 2.6934 0.94 2577 99 0.3808 0.4123 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.37 REMARK 3 B_SOL : 39.43 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.350 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 28.660 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 50.56 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 62.50 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -10.54750 REMARK 3 B22 (A**2) : -8.23980 REMARK 3 B33 (A**2) : 13.83570 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.61130 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.005 4744 REMARK 3 ANGLE : 0.777 6440 REMARK 3 CHIRALITY : 0.054 700 REMARK 3 PLANARITY : 0.004 828 REMARK 3 DIHEDRAL : 14.163 1680 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 4 REMARK 3 TLS GROUP : 1 REMARK 3 SELECTION: CHAIN A REMARK 3 ORIGIN FOR THE GROUP (A): -40.0871 2.7776 12.7107 REMARK 3 T TENSOR REMARK 3 T11: 0.0422 T22: 0.1776 REMARK 3 T33: 0.1204 T12: -0.0500 REMARK 3 T13: 0.0341 T23: 0.0068 REMARK 3 L TENSOR REMARK 3 L11: 1.0950 L22: 2.0780 REMARK 3 L33: 0.6404 L12: -0.1026 REMARK 3 L13: -0.3664 L23: 0.3120 REMARK 3 S TENSOR REMARK 3 S11: 0.0264 S12: -0.1338 S13: 0.0256 REMARK 3 S21: 0.0852 S22: -0.1448 S23: -0.1245 REMARK 3 S31: 0.0490 S32: -0.0179 S33: 0.0826 REMARK 3 TLS GROUP : 2 REMARK 3 SELECTION: CHAIN B REMARK 3 ORIGIN FOR THE GROUP (A): -79.8836 -2.7539 19.7358 REMARK 3 T TENSOR REMARK 3 T11: 0.2901 T22: 0.1429 REMARK 3 T33: 0.4270 T12: 0.0556 REMARK 3 T13: -0.1171 T23: -0.0237 REMARK 3 L TENSOR REMARK 3 L11: 3.5725 L22: -0.3931 REMARK 3 L33: 1.6448 L12: 1.0957 REMARK 3 L13: -1.0984 L23: -0.6158 REMARK 3 S TENSOR REMARK 3 S11: -0.0569 S12: 0.0681 S13: -0.5158 REMARK 3 S21: -0.0849 S22: -0.1409 S23: 0.0174 REMARK 3 S31: 0.2176 S32: 0.0372 S33: 0.2128 REMARK 3 TLS GROUP : 3 REMARK 3 SELECTION: CHAIN C REMARK 3 ORIGIN FOR THE GROUP (A): -20.8903 -3.0435 25.5946 REMARK 3 T TENSOR REMARK 3 T11: 0.2456 T22: 0.1663 REMARK 3 T33: 0.4462 T12: 0.0315 REMARK 3 T13: -0.0694 T23: 0.0398 REMARK 3 L TENSOR REMARK 3 L11: 3.5203 L22: 0.0122 REMARK 3 L33: 2.1519 L12: 0.6370 REMARK 3 L13: -0.3785 L23: -0.2062 REMARK 3 S TENSOR REMARK 3 S11: -0.0942 S12: -0.2057 S13: -0.3994 REMARK 3 S21: -0.1311 S22: 0.0033 S23: 0.0901 REMARK 3 S31: 0.2067 S32: -0.0925 S33: 0.0849 REMARK 3 TLS GROUP : 4 REMARK 3 SELECTION: CHAIN D REMARK 3 ORIGIN FOR THE GROUP (A): -62.0100 4.2109 33.3564 REMARK 3 T TENSOR REMARK 3 T11: 0.2075 T22: 0.0886 REMARK 3 T33: 0.1211 T12: 0.0349 REMARK 3 T13: -0.0362 T23: -0.0103 REMARK 3 L TENSOR REMARK 3 L11: 2.5258 L22: 0.8843 REMARK 3 L33: 3.2589 L12: 0.0872 REMARK 3 L13: 0.3749 L23: -0.1527 REMARK 3 S TENSOR REMARK 3 S11: -0.0150 S12: 0.0550 S13: -0.0019 REMARK 3 S21: -0.0530 S22: -0.0692 S23: -0.0463 REMARK 3 S31: -0.1896 S32: 0.0491 S33: 0.0036 REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : 1 REMARK 3 NCS GROUP : 1 REMARK 3 NCS OPERATOR : 1 REMARK 3 REFERENCE SELECTION: CHAIN A REMARK 3 SELECTION : CHAIN B AND NOT (RESID 1:9 OR RESID 27:28 REMARK 3 OR RESID 42:45 OR RESID 117:120 ) REMARK 3 ATOM PAIRS NUMBER : 1051 REMARK 3 RMSD : 0.029 REMARK 3 NCS OPERATOR : 2 REMARK 3 REFERENCE SELECTION: CHAIN A REMARK 3 SELECTION : CHAIN C AND NOT (RESID 1:9 OR RESID 27:28 REMARK 3 OR RESID 42:45 OR RESID 117:120 ) REMARK 3 ATOM PAIRS NUMBER : 1051 REMARK 3 RMSD : 0.026 REMARK 3 NCS OPERATOR : 3 REMARK 3 REFERENCE SELECTION: CHAIN A REMARK 3 SELECTION : CHAIN D AND NOT (RESID 1:9 OR RESID 27:28 REMARK 3 OR RESID 42:45 OR RESID 117:120 ) REMARK 3 ATOM PAIRS NUMBER : 1047 REMARK 3 RMSD : 0.028 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: B VALUES INCLUDE TLS CONTRIBUTIONS. REMARK 4 REMARK 4 2VVY COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 12-JUN-08. REMARK 100 THE DEPOSITION ID IS D_1290036550. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 08-JUL-05 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : BM14 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.8856 REMARK 200 MONOCHROMATOR : SI(111) CRYSTAL REMARK 200 OPTICS : MIRRORS REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : MARRESEARCH REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 19127 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.700 REMARK 200 RESOLUTION RANGE LOW (A) : 50.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 200 DATA REDUNDANCY : 3.700 REMARK 200 R MERGE (I) : 0.12000 REMARK 200 R SYM (I) : NULL REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.70 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.80 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.6 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.84000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 1.800 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MAD REMARK 200 SOFTWARE USED: HKL2MAP REMARK 200 STARTING MODEL: NONE REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 44.10 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.20 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SITTING DROPS CONTAINING 100 NL REMARK 280 PROTEIN (3.2 MG/ML IN 50 MM TRIS PH 8.5, 150 MM NACL, 2 MM 2- REMARK 280 MERCAPTOETHANOL) AND 100 NL RESERVOIR SOLUTION (0.2 M DIAMMONIUM REMARK 280 TARTRATE, 20% (W/V) PEG 3350, 0.4 M NON-DETERGENT SULPHOBETANE REMARK 280 201 AND 2 MM 2-MERCAPTOETHANOL) WERE EQUILIBRATED AGAINST 95 UL REMARK 280 RESERVOIRS AT 21 C. CRYSTALS WERE CRYOPROTECTED IN RESERVOIR REMARK 280 SOLUTION SUPPLEMENTED WITH 20% (V/V) GLYCEROL., VAPOR DIFFUSION, REMARK 280 SITTING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 84.33650 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 21.94200 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 84.33650 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 21.94200 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 2020 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15690 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -13.7 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 1810 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15560 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -10.9 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: B, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A -19 REMARK 465 GLY A -18 REMARK 465 SER A -17 REMARK 465 SER A -16 REMARK 465 HIS A -15 REMARK 465 HIS A -14 REMARK 465 HIS A -13 REMARK 465 HIS A -12 REMARK 465 HIS A -11 REMARK 465 HIS A -10 REMARK 465 SER A -9 REMARK 465 SER A -8 REMARK 465 GLY A -7 REMARK 465 LEU A -6 REMARK 465 VAL A -5 REMARK 465 PRO A -4 REMARK 465 ARG A -3 REMARK 465 GLY A -2 REMARK 465 SER A -1 REMARK 465 HIS A 0 REMARK 465 MSE A 1 REMARK 465 THR A 2 REMARK 465 ALA A 3 REMARK 465 ASN A 4 REMARK 465 PHE A 5 REMARK 465 SER A 6 REMARK 465 THR A 7 REMARK 465 MSE B -19 REMARK 465 GLY B -18 REMARK 465 SER B -17 REMARK 465 SER B -16 REMARK 465 HIS B -15 REMARK 465 HIS B -14 REMARK 465 HIS B -13 REMARK 465 HIS B -12 REMARK 465 HIS B -11 REMARK 465 HIS B -10 REMARK 465 SER B -9 REMARK 465 SER B -8 REMARK 465 GLY B -7 REMARK 465 LEU B -6 REMARK 465 VAL B -5 REMARK 465 PRO B -4 REMARK 465 ARG B -3 REMARK 465 GLY B -2 REMARK 465 SER B -1 REMARK 465 HIS B 0 REMARK 465 MSE B 1 REMARK 465 THR B 2 REMARK 465 ALA B 3 REMARK 465 ASN B 4 REMARK 465 PHE B 5 REMARK 465 SER B 6 REMARK 465 THR B 7 REMARK 465 MSE C -19 REMARK 465 GLY C -18 REMARK 465 SER C -17 REMARK 465 SER C -16 REMARK 465 HIS C -15 REMARK 465 HIS C -14 REMARK 465 HIS C -13 REMARK 465 HIS C -12 REMARK 465 HIS C -11 REMARK 465 HIS C -10 REMARK 465 SER C -9 REMARK 465 SER C -8 REMARK 465 GLY C -7 REMARK 465 LEU C -6 REMARK 465 VAL C -5 REMARK 465 PRO C -4 REMARK 465 ARG C -3 REMARK 465 GLY C -2 REMARK 465 SER C -1 REMARK 465 HIS C 0 REMARK 465 MSE C 1 REMARK 465 THR C 2 REMARK 465 ALA C 3 REMARK 465 ASN C 4 REMARK 465 PHE C 5 REMARK 465 SER C 6 REMARK 465 THR C 7 REMARK 465 MSE D -19 REMARK 465 GLY D -18 REMARK 465 SER D -17 REMARK 465 SER D -16 REMARK 465 HIS D -15 REMARK 465 HIS D -14 REMARK 465 HIS D -13 REMARK 465 HIS D -12 REMARK 465 HIS D -11 REMARK 465 HIS D -10 REMARK 465 SER D -9 REMARK 465 SER D -8 REMARK 465 GLY D -7 REMARK 465 LEU D -6 REMARK 465 VAL D -5 REMARK 465 PRO D -4 REMARK 465 ARG D -3 REMARK 465 GLY D -2 REMARK 465 SER D -1 REMARK 465 HIS D 0 REMARK 465 MSE D 1 REMARK 465 THR D 2 REMARK 465 ALA D 3 REMARK 465 ASN D 4 REMARK 465 PHE D 5 REMARK 465 SER D 6 REMARK 465 THR D 7 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 13 CG CD OE1 NE2 REMARK 470 GLU A 70 CG CD OE1 OE2 REMARK 470 GLN B 13 CG CD OE1 NE2 REMARK 470 GLU B 70 CG CD OE1 OE2 REMARK 470 GLN C 13 CG CD OE1 NE2 REMARK 470 GLU C 70 CG CD OE1 OE2 REMARK 470 GLN D 13 CG CD OE1 NE2 REMARK 470 GLN D 95 CG CD OE1 NE2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 39 -27.29 -167.85 REMARK 500 ILE A 66 -89.75 64.70 REMARK 500 TYR B 39 -28.24 -168.40 REMARK 500 ILE B 66 -90.81 63.27 REMARK 500 TYR C 39 -28.10 -169.16 REMARK 500 ILE C 66 -89.71 64.60 REMARK 500 TYR D 39 -26.63 -167.77 REMARK 500 ILE D 66 -90.76 64.97 REMARK 500 REMARK 500 REMARK: NULL REMARK 650 REMARK 650 HELIX REMARK 650 DETERMINATION METHOD: AUTHOR PROVIDED. REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 2VVX RELATED DB: PDB REMARK 900 STRUCTURE OF VACCINIA VIRUS PROTEIN A52 REMARK 900 RELATED ID: 2VVW RELATED DB: PDB REMARK 900 STRUCTURE OF VACCINIA VIRUS PROTEIN A52 REMARK 900 RELATED ID: 2I39 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF VACCINIA VIRUS N1L PROTEIN REMARK 900 RELATED ID: 2UXE RELATED DB: PDB REMARK 900 THE STRUCTURE OF VACCINIA VIRUS N1 REMARK 900 RELATED ID: 2JBX RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE MYXOMA VIRUS ANTI- APOPTOTIC PROTEIN M11L REMARK 900 RELATED ID: 2JBY RELATED DB: PDB REMARK 900 A VIRAL PROTEIN UNEXPECTEDLY MIMICS THE STRUCTURE AND FUNCTION OF REMARK 900 PRO-SURVIVAL BCL-2 REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE ADDED N-TERMINAL HIS6 FUSION TAG AND THROMBIN REMARK 999 CLEAVAGE SITE ARISE FROM THE PET-28A EXPRESSION VECTOR. DBREF 2VVY A -19 0 PDB 2VVY 2VVY -19 0 DBREF 2VVY A 1 149 UNP P24772 VB15_VACCV 1 149 DBREF 2VVY B -19 0 PDB 2VVY 2VVY -19 0 DBREF 2VVY B 1 149 UNP P24772 VB15_VACCV 1 149 DBREF 2VVY C -19 0 PDB 2VVY 2VVY -19 0 DBREF 2VVY C 1 149 UNP P24772 VB15_VACCV 1 149 DBREF 2VVY D -19 0 PDB 2VVY 2VVY -19 0 DBREF 2VVY D 1 149 UNP P24772 VB15_VACCV 1 149 SEQRES 1 A 169 MSE GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 A 169 LEU VAL PRO ARG GLY SER HIS MSE THR ALA ASN PHE SER SEQRES 3 A 169 THR HIS VAL PHE SER PRO GLN HIS CYS GLY CYS ASP ARG SEQRES 4 A 169 LEU THR SER ILE ASP ASP VAL ARG GLN CYS LEU THR GLU SEQRES 5 A 169 TYR ILE TYR TRP SER SER TYR ALA TYR ARG ASN ARG GLN SEQRES 6 A 169 CYS ALA GLY GLN LEU TYR SER THR LEU LEU SER PHE ARG SEQRES 7 A 169 ASP ASP ALA GLU LEU VAL PHE ILE ASP ILE ARG GLU LEU SEQRES 8 A 169 VAL LYS ASN MSE PRO TRP ASP ASP VAL LYS ASP CYS ALA SEQRES 9 A 169 GLU ILE ILE ARG CYS TYR ILE PRO ASP GLU GLN LYS THR SEQRES 10 A 169 ILE ARG GLU ILE SER ALA ILE ILE GLY LEU CYS ALA TYR SEQRES 11 A 169 ALA ALA THR TYR TRP GLY GLY GLU ASP HIS PRO THR SER SEQRES 12 A 169 ASN SER LEU ASN ALA LEU PHE VAL MSE LEU GLU MSE LEU SEQRES 13 A 169 ASN TYR VAL ASP TYR ASN ILE ILE PHE ARG ARG MSE ASN SEQRES 1 B 169 MSE GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 B 169 LEU VAL PRO ARG GLY SER HIS MSE THR ALA ASN PHE SER SEQRES 3 B 169 THR HIS VAL PHE SER PRO GLN HIS CYS GLY CYS ASP ARG SEQRES 4 B 169 LEU THR SER ILE ASP ASP VAL ARG GLN CYS LEU THR GLU SEQRES 5 B 169 TYR ILE TYR TRP SER SER TYR ALA TYR ARG ASN ARG GLN SEQRES 6 B 169 CYS ALA GLY GLN LEU TYR SER THR LEU LEU SER PHE ARG SEQRES 7 B 169 ASP ASP ALA GLU LEU VAL PHE ILE ASP ILE ARG GLU LEU SEQRES 8 B 169 VAL LYS ASN MSE PRO TRP ASP ASP VAL LYS ASP CYS ALA SEQRES 9 B 169 GLU ILE ILE ARG CYS TYR ILE PRO ASP GLU GLN LYS THR SEQRES 10 B 169 ILE ARG GLU ILE SER ALA ILE ILE GLY LEU CYS ALA TYR SEQRES 11 B 169 ALA ALA THR TYR TRP GLY GLY GLU ASP HIS PRO THR SER SEQRES 12 B 169 ASN SER LEU ASN ALA LEU PHE VAL MSE LEU GLU MSE LEU SEQRES 13 B 169 ASN TYR VAL ASP TYR ASN ILE ILE PHE ARG ARG MSE ASN SEQRES 1 C 169 MSE GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 C 169 LEU VAL PRO ARG GLY SER HIS MSE THR ALA ASN PHE SER SEQRES 3 C 169 THR HIS VAL PHE SER PRO GLN HIS CYS GLY CYS ASP ARG SEQRES 4 C 169 LEU THR SER ILE ASP ASP VAL ARG GLN CYS LEU THR GLU SEQRES 5 C 169 TYR ILE TYR TRP SER SER TYR ALA TYR ARG ASN ARG GLN SEQRES 6 C 169 CYS ALA GLY GLN LEU TYR SER THR LEU LEU SER PHE ARG SEQRES 7 C 169 ASP ASP ALA GLU LEU VAL PHE ILE ASP ILE ARG GLU LEU SEQRES 8 C 169 VAL LYS ASN MSE PRO TRP ASP ASP VAL LYS ASP CYS ALA SEQRES 9 C 169 GLU ILE ILE ARG CYS TYR ILE PRO ASP GLU GLN LYS THR SEQRES 10 C 169 ILE ARG GLU ILE SER ALA ILE ILE GLY LEU CYS ALA TYR SEQRES 11 C 169 ALA ALA THR TYR TRP GLY GLY GLU ASP HIS PRO THR SER SEQRES 12 C 169 ASN SER LEU ASN ALA LEU PHE VAL MSE LEU GLU MSE LEU SEQRES 13 C 169 ASN TYR VAL ASP TYR ASN ILE ILE PHE ARG ARG MSE ASN SEQRES 1 D 169 MSE GLY SER SER HIS HIS HIS HIS HIS HIS SER SER GLY SEQRES 2 D 169 LEU VAL PRO ARG GLY SER HIS MSE THR ALA ASN PHE SER SEQRES 3 D 169 THR HIS VAL PHE SER PRO GLN HIS CYS GLY CYS ASP ARG SEQRES 4 D 169 LEU THR SER ILE ASP ASP VAL ARG GLN CYS LEU THR GLU SEQRES 5 D 169 TYR ILE TYR TRP SER SER TYR ALA TYR ARG ASN ARG GLN SEQRES 6 D 169 CYS ALA GLY GLN LEU TYR SER THR LEU LEU SER PHE ARG SEQRES 7 D 169 ASP ASP ALA GLU LEU VAL PHE ILE ASP ILE ARG GLU LEU SEQRES 8 D 169 VAL LYS ASN MSE PRO TRP ASP ASP VAL LYS ASP CYS ALA SEQRES 9 D 169 GLU ILE ILE ARG CYS TYR ILE PRO ASP GLU GLN LYS THR SEQRES 10 D 169 ILE ARG GLU ILE SER ALA ILE ILE GLY LEU CYS ALA TYR SEQRES 11 D 169 ALA ALA THR TYR TRP GLY GLY GLU ASP HIS PRO THR SER SEQRES 12 D 169 ASN SER LEU ASN ALA LEU PHE VAL MSE LEU GLU MSE LEU SEQRES 13 D 169 ASN TYR VAL ASP TYR ASN ILE ILE PHE ARG ARG MSE ASN MODRES 2VVY MSE A 75 MET SELENOMETHIONINE MODRES 2VVY MSE A 132 MET SELENOMETHIONINE MODRES 2VVY MSE A 135 MET SELENOMETHIONINE MODRES 2VVY MSE A 148 MET SELENOMETHIONINE MODRES 2VVY MSE B 75 MET SELENOMETHIONINE MODRES 2VVY MSE B 132 MET SELENOMETHIONINE MODRES 2VVY MSE B 135 MET SELENOMETHIONINE MODRES 2VVY MSE B 148 MET SELENOMETHIONINE MODRES 2VVY MSE C 75 MET SELENOMETHIONINE MODRES 2VVY MSE C 132 MET SELENOMETHIONINE MODRES 2VVY MSE C 135 MET SELENOMETHIONINE MODRES 2VVY MSE C 148 MET SELENOMETHIONINE MODRES 2VVY MSE D 75 MET SELENOMETHIONINE MODRES 2VVY MSE D 132 MET SELENOMETHIONINE MODRES 2VVY MSE D 135 MET SELENOMETHIONINE MODRES 2VVY MSE D 148 MET SELENOMETHIONINE HET MSE A 75 8 HET MSE A 132 8 HET MSE A 135 8 HET MSE A 148 8 HET MSE B 75 8 HET MSE B 132 8 HET MSE B 135 8 HET MSE B 148 8 HET MSE C 75 8 HET MSE C 132 8 HET MSE C 135 8 HET MSE C 148 8 HET MSE D 75 8 HET MSE D 132 8 HET MSE D 135 8 HET MSE D 148 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 16(C5 H11 N O2 SE) HELIX 1 1 ASP A 25 TRP A 36 1 12 HELIX 2 2 GLN A 49 PHE A 65 1 17 HELIX 3 3 ILE A 68 ASN A 74 1 7 HELIX 4 4 VAL A 80 TYR A 90 1 11 HELIX 5 5 ILE A 98 TRP A 115 1 18 HELIX 6 6 SER A 123 MSE A 135 1 13 HELIX 7 7 TYR A 138 PHE A 145 1 8 HELIX 8 1 ASP B 25 TRP B 36 1 12 HELIX 9 2 GLN B 49 PHE B 65 1 17 HELIX 10 3 ILE B 68 ASN B 74 1 7 HELIX 11 4 VAL B 80 TYR B 90 1 11 HELIX 12 5 ILE B 98 TRP B 115 1 18 HELIX 13 6 SER B 123 MSE B 135 1 13 HELIX 14 7 TYR B 138 PHE B 145 1 8 HELIX 15 1 ASP C 25 TRP C 36 1 12 HELIX 16 2 GLN C 49 PHE C 65 1 17 HELIX 17 3 ILE C 68 ASN C 74 1 7 HELIX 18 4 VAL C 80 TYR C 90 1 11 HELIX 19 5 ILE C 98 TRP C 115 1 18 HELIX 20 6 SER C 123 MSE C 135 1 13 HELIX 21 7 TYR C 138 PHE C 145 1 8 HELIX 22 1 ASP D 25 TRP D 36 1 12 HELIX 23 2 GLN D 49 PHE D 65 1 17 HELIX 24 3 ILE D 68 ASN D 74 1 7 HELIX 25 4 VAL D 80 TYR D 90 1 11 HELIX 26 5 ILE D 98 TRP D 115 1 18 HELIX 27 6 SER D 123 MSE D 135 1 13 HELIX 28 7 TYR D 138 PHE D 145 1 8 SSBOND 1 CYS A 15 CYS A 46 1555 1555 2.04 SSBOND 2 CYS B 15 CYS B 46 1555 1555 2.04 SSBOND 3 CYS C 15 CYS C 46 1555 1555 2.04 SSBOND 4 CYS D 15 CYS D 46 1555 1555 2.03 LINK C ASN A 74 N MSE A 75 1555 1555 1.33 LINK C MSE A 75 N PRO A 76 1555 1555 1.34 LINK C VAL A 131 N MSE A 132 1555 1555 1.33 LINK C MSE A 132 N LEU A 133 1555 1555 1.33 LINK C GLU A 134 N MSE A 135 1555 1555 1.33 LINK C MSE A 135 N LEU A 136 1555 1555 1.33 LINK C ARG A 147 N MSE A 148 1555 1555 1.33 LINK C MSE A 148 N ASN A 149 1555 1555 1.33 LINK C ASN B 74 N MSE B 75 1555 1555 1.33 LINK C MSE B 75 N PRO B 76 1555 1555 1.35 LINK C VAL B 131 N MSE B 132 1555 1555 1.33 LINK C MSE B 132 N LEU B 133 1555 1555 1.33 LINK C GLU B 134 N MSE B 135 1555 1555 1.33 LINK C MSE B 135 N LEU B 136 1555 1555 1.33 LINK C ARG B 147 N MSE B 148 1555 1555 1.33 LINK C MSE B 148 N ASN B 149 1555 1555 1.33 LINK C ASN C 74 N MSE C 75 1555 1555 1.33 LINK C MSE C 75 N PRO C 76 1555 1555 1.35 LINK C VAL C 131 N MSE C 132 1555 1555 1.32 LINK C MSE C 132 N LEU C 133 1555 1555 1.33 LINK C GLU C 134 N MSE C 135 1555 1555 1.33 LINK C MSE C 135 N LEU C 136 1555 1555 1.33 LINK C ARG C 147 N MSE C 148 1555 1555 1.33 LINK C MSE C 148 N ASN C 149 1555 1555 1.33 LINK C ASN D 74 N MSE D 75 1555 1555 1.33 LINK C MSE D 75 N PRO D 76 1555 1555 1.35 LINK C VAL D 131 N MSE D 132 1555 1555 1.33 LINK C MSE D 132 N LEU D 133 1555 1555 1.33 LINK C GLU D 134 N MSE D 135 1555 1555 1.33 LINK C MSE D 135 N LEU D 136 1555 1555 1.33 LINK C ARG D 147 N MSE D 148 1555 1555 1.33 LINK C MSE D 148 N ASN D 149 1555 1555 1.34 CRYST1 168.673 43.884 99.878 90.00 112.09 90.00 C 1 2 1 16 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.005929 0.000000 0.002406 0.00000 SCALE2 0.000000 0.022787 0.000000 0.00000 SCALE3 0.000000 0.000000 0.010805 0.00000